Main Text
1 Introduction
Type 2 diabetic peripheral neuropathy (T2DPN) is the commonest chronic complication of diabetes, featuring numbness of limbs and spontaneous pain that seriously affect the life quality of patients [1]. The high blood glucose can incur the increase of advanced glycation end products and activate the advanced glycation end product and hexosamine pathways, so as to enhance inflammatory response signals, damage neurons, neurogliocytes, vascular endothelial cells, etc., and ultimately trigger T2DPN [2,3]. Currently, in Western medicine, there is no specific treatment method for T2DPN but only symptom-based therapy, including metabolism regulation and nerve nourishing; however, the therapeutic efficacy is poor in some patients and other combined drugs are required [4]. Fortunately, traditional Chinese medicine (TCM) has clear efficacy against T2DPN, which combined with Western medicine is a common method for T2DPN clinically [5].
In TCM, T2DPN belongs to “blood impediment”, the pathogenesis of which is dual deficiency of qi and yin, as well as weakened blood circulation, resulting in phlegm turbidity, blood stasis, obstruction of meridians and collaterals, and ultimate numbness of limbs and pain; therefore, treatment of T2DPN should focus on transforming stasis, unblocking collaterals, nourishing yin and benefiting qi [6]. As a traditional therapy with a long history, acupuncture is mainly responsible for unblocking collaterals, regulating qi and blood, moving impediment disorder and alleviating pain, which exerts notable efficacy on reducing blood glucose and improving neuropathy [7]. Shenqi Jiangtang granules is composed of ginsenoside, Astragalus Radix, Dioscoreae Rhizoma, etc., with the efficacy of reinforcing qi and nourishing yin as well as strengthening kidney and nourishing spleen, which can effectively mitigate numbness of limbs and pain caused by qi stagnation, blood stasis, and stasis obstructing the collaterals [8]. Shenqi Jiangtang granule is an effective and safe adjuvant therapy for type 2 diabetes mellitus [9]. In addition, it has been reported that Shenqi Jiangtang granule combined with Western medicine has a good therapeutic effect on gestational diabetes mellitus (GDM) patients, which can effectively control blood glucose and lipid levels, and reduce the incidence of adverse pregnancy outcomes [10,11].
On this basis, this study probes into the efficacy of Shenqi Jiangtang granules combined with acupuncture on T2DPN with dual deficiency of qi and yin, so as to provide valuable references to T2DPN treatment.
2 Materials and methods
2.1 General information
48 patients with T2DPN and dual deficiency of qi and yin, who were admitted to our hospital and received treatment of Shenqi Jiangtang granules combined with acupuncture from April, 2021 to April, 2023 (termed observation group). Meanwhile, the other 48 patients with the same disease and symptoms receiving acupuncture treatment were set as a control group. The general information of the two groups had no obvious difference and was comparable (Table 1). This study was authorized by the Ethics Committee of our hospital and the written informed consent was obtained from all patients.
Table 1 The comparison of general information between the two groups of patients.
Group | Case | Sex (case) | Age (year old) | Course of disease (year) | FBG (mmol/L) | P2hBG (mmol/L) | HbAlc (%) | Complication (case) | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Male | Female | Hyperlipidemia | Hypertension | Coronary heart disease | |||||||
Observation group | 48 | 26 | 22 | 60.57 ± 6.62 | 5.05 ± 0.60 | 8.73 ± 0.92 | 14.38 ± 1.74 | 8.23 ± 0.91 | 13 | 16 | 8 |
Control group | 48 | 25 | 23 | 61.03 ± 6.38 | 5.09 ± 0.56 | 8.61 ± 0.88 | 14.45 ± 1.86 | 8.20 ± 0.90 | 12 | 15 | 8 |
X2/t | 0.042 | 0.347 | 0.338 | 0.653 | 0.190 | 0.162 | 0.017 | ||||
p | 0.838 | 0.730 | 0.736 | 0.515 | 0.849 | 0.871 | 0.992 |
2.2 Inclusion criteria
Patients who (1) suffered from T2DPN meeting the diagnostic criteria of Western medicine from Consensus on diagnosis and treatment of diabetic peripheral neuropathy [12]; (2) suffered from T2DPN belonging to symptoms of dual deficiency of qi and yin as well as blood stasis in Guiding principles for clinical research of new Chinese medicine [13], with the main symptoms of numbness, sense of coldness and formication of both lower limbs, accompanied by frequent micturition with profuse urine, dry mouth and heavy drinking, blurred vision, and secondary symptoms of red tongue with little fluid, less and dry tongue coating, as well as thin and hesitant pulse [13]; (3) had disease course of diabetes mellitus (DM) > 1 year; and (4) took no DPN drugs within 1 month.
2.3 Exclusion criteria
Patients who (1) suffered from peripheral neuropathy caused by other diseases; (2) failed to effectively control blood glucose; (3) were inappropriate for further treatment due to acute complications such as ketoacidosis and coma, and deterioration of disease; (4) were allergic to components of Shenqi Jiangtang granules; (5) were lactating or pregnant women; (6) complicated with heart, lung, liver and kidney dysfunction; and (7) were accompanied with malignant tumors.
2.4 Treatment methods
All patients stopped taking antidiabetic drugs and received unified conventional treatment, including healthy promotion and education, diet intervention, control of blood glucose using metformin alone or combined with insulin, and nerve nourishing using lipoic acid and mecobalamin. Based on conventional therapy, patients in control group received acupuncture, mainly with Yuan-primordial points of channels, including Zusanli, the sea of blood, Taixi, Taichong, Taibai, Chongyang, Qiuxu, and Chingku, while patients complicated with upper limb symptoms had additional acupuncture in Yangchi, Hegu, Dalin, Taiyuan, Wangu and Shenmen. Concretely, following location of acupoint, iodophor disinfection was conducted, and filiform needle acupuncture was later performed according to balanced reinforcing and reducing methods; during the process, needle would be retained for 20 min when the desired sensation was brought about; the operation was conducted once every other day. On the basis of the treatment in control group, patients in observation group additionally took Shenqi Jiangtang granules (batch number:00116221, 00117096, 01180741, Lunan Hopu Pharmaceutical Co., Ltd., National medicine permission number: Z10950075, 3 g/bag) orally, 3 g/time and 3 times/day. All patients in the two groups were treated for a month and stopped taking drugs for a week, and the treatment lasted for 3 months.
2.5 Observation indicators
This study collected clinical data on TCM symptom scores, pancreas islet function indicators, nerve conduction index levels, etc. that were tested and registered during treatment in two groups of T2DPN patients. Based on medical records, the changes in symptoms and the occurrence of adverse events during treatment were gathered.
(1) Clinical efficacy: the clinical efficacy was compared between the two groups of patients after 3 months of treatment. Obvious effectiveness: pain, numbness and other symptoms were greatly improved, tendon reflexes recovered significantly, and nerve conduction velocity (NCV) was increased by 5 m/s. Effectiveness: pain, numbness and other symptoms were relatively improved, tendon reflexes gradually recovered, and NCV was increased by over 3 m/s. Ineffectiveness: pain, numbness and other symptoms did not change, tendon reflexes did not recover, and NCV was increased less than 3 m/s. Total effectiveness = (Obvious effectiveness + Effectiveness)/Total cases ×100% [13].
(2) TCM symptom score: The TCM symptom score was contrasted between the two groups of patients before treatment and 3 months after treatment. According to TCM syndromes and clinical signs, a score scale was established, containing 6 items of excessive eating and frequent hunger, fatigue, lack of energy and laziness in speech, lukewarm hands and feet, rough and scaly skin, and numbness of limbs or pain in limbs. Before and after treatment, scores were given based on the severity of each item (0 point for no symptoms, 1 for mild symptom, 2 for moderate symptom, and 3 for severe symptom), with higher scores indicating more severe symptoms [13].
(3) Pancreas islet function: The pancreas islet function was compared between the two groups of patients before treatment and 3 months after treatment. 5 ml of fasting venous blood was extracted in the morning and centrifuged at 4000 r/min for 5 min. Fasting serum insulin level was measured using an immunochemiluminescence analyzer (Elecsys2010, Roche, Germany). The formula for calculating insulin resistance index: (fasting blood glucose × fasting insulin)/22.5 [14].
(4) Nerve conduction condition: The nerve conduction level was contrasted between patients of the two groups before treatment and 3 months after treatment. Electromyography and evoked potential test devices were applied to detect the sensory nerve conduction velocity (SNCV) and motor nerve conduction velocity (MNCV) of median nerve, posterior tibial nerve and common peroneal nerve.
(5) Adverse reaction: The possible adverse reactions that may occur between two groups of patients were collected and compared during treatment.
2.6 Statistical analysis
SPSS 20.0 was employed to conduct statistical analyses. Statistical data were compared by x2 test, and measurement data were expressed by means ± standard deviation. The Kruskal-Wallis method was used for normality analysis of continuous variables, and t-test was for analyzing continuous variables that conform to normal distribution. Independent samples t-test was applied for two-group comparison, and paired samples t-test was for comparison before and after treatment in the same group. p < 0.05 was considered to be statistically significant.
3 Results
3.1 Comparison of clinical efficacy in the two groups of patients
The total effective rate was higher in observation group than control group (p < 0.05, Table 2).
Table 2 Comparison of clinical efficacy between the two groups of patients [case (%)].
Group | Case | Obvious effectiveness | Effectiveness | Ineffectiveness | Total effective rate |
---|---|---|---|---|---|
Observation group | 48 | 32 (66.67) | 13 (27.08) | 3 (6.25) | 45 (93.75) |
Control group | 48 | 28 (58.33) | 10 (20.83) | 10 (20.83) | 38 (79.17) |
χ2 | 4.360 | ||||
p | 0.037 |
3.2 Comparison of TCM symptom score between the two groups of patients before and after treatment
Prior to treatment, there was no apparent difference between the two groups of patients in TCM symptom scores (p > 0.05, Table 3), but after treatment, the score was declined in the two groups of patients and the decreasing trend was more remarkable in observation group than control group (p < 0.05, Table 3).
Table 3 Comparison of TCM symptom score between the two groups of patients (means ± standard deviation, score).
Group | Case | Before treatment | After treatment |
---|---|---|---|
Observation group | 48 | 8.21 ± 0.87 | 6.26 ± 0.76 * |
Control group | 48 | 8.25 ± 0.90 | 6.92 ± 0.81 * |
t | 0.221 | 2.869 | |
p | 0.825 | 0.005 |
Note: * p < 0.05 vs. before treatment.
3.3 Comparison of pancreas islet function between the two groups of patients before and after treatment
Fasting insulin level and insulin resistance index were similar in the two groups of patients before treatment (p > 0.05, Table 4). Notably, the two indicators in both groups of patients were diminished following treatment, and the two indicators were lower in observation group than control group (p < 0.05, Table 4).
Table 4 Comparison of pancreas islet function between the two groups of patients before and after treatment (means ± standard deviation).
Group | Case | Fasting insulin level (mIU/L) | Insulin resistance index | ||
---|---|---|---|---|---|
Before treatment | After treatment | Before treatment | After treatment | ||
Observation group | 48 | 9.74 ± 1.02 | 6.42 ± 0.71 * | 3.25 ± 0.50 | 1.46 ± 0.28 * |
Control group | 48 | 9.45 ± 0.87 | 8.08 ± 0.82 * | 3.19 ± 0.48 | 2.05 ± 0.40 * |
t | 1.499 | 10.603 | 0.600 | 8.372 | |
p | 0.137 | <0.001 | 0.550 | <0.001 |
Note: * p < 0.05 vs. before treatment.
3.4 Comparison of nerve conduction level between the two groups of patients before and after treatment
The SNCV and MNCV of median nerve, posterior tibial nerve and common peroneal nerve were barely different in the two groups of patients before treatment (p > 0.05), but later elevated by treatment (p < 0.05, Table 5). The elevation was more marked in observation group than control group (p < 0.05, Table 5).
Table 5 Comparison of nerve conduction level between the two groups of patients before and after treatment (means ± standard deviation, m/s).
Group | Case | MNCV of median nerve | MNCV of posterior tibial nerve | MNCV of common peroneal nerve | SNCV of median nerve | SNCV of posterior tibial nerve | SNCV of common peroneal nerve | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | ||
Observation group | 48 | 44.08 ± 4.12 | 51.60 ± 3.42 * | 39.21 ± 3.05 | 45.20 ± 2.16 * | 38.92 ± 3.27 | 46.67 ± 2.82 * | 41.55 ± 3.45 | 47.12 ± 2.37 * | 33.51 ± 3.01 | 40.26 ± 2.41 * | 38.67 ± 3.06 | 45.92 ± 2.06 * |
Control group | 48 | 44.81 ± 4.23 | 47.05 ± 3.84 * | 39.75 ± 3.31 | 43.66 ± 2.31 * | 39.21 ± 3.38 | 43.62 ± 2.78 * | 42.03 ± 3.31 | 45.81 ± 2.80 * | 34.12 ± 3.12 | 37.26 ± 2.61 * | 38.88 ± 3.17 | 42.81 ± 2.12 * |
t | 0.857 | 6.130 | 0.831 | 3.374 | 0.427 | 5.336 | 0.696 | 2.474 | 0.975 | 5.851 | 0.330 | 7.289 | |
p | 0.394 | <0.001 | 0.408 | 0.001 | 0.670 | <0.001 | 0.488 | 0.015 | 0.332 | <0.001 | 0.742 | <0.001 |
Note: * p < 0.05 vs. before treatment.
3.5 Comparison of adverse reactions between the two groups of patients
There were no severe adverse reactions in the two groups of patientss.
4 Discussion
To delve into effective methods for T2DPN with dual deficiency of qi and yin, this study included 48 patients receiving treatment of Shenqi Jiangtang granules combined with acupuncture and the other 48 patients only undergoing acupuncture treatment, and compared the clinical efficacy between the two groups of patients. The results confirmed that the therapeutic efficacy was more significant in T2DPN patients with dual deficiency of qi and yin after treatment of Shenqi Jiangtang granules combined with acupuncture.
The chronic high blood glucose in T2DPN patients may cause reduced sensitivity of β-insulin cells to blood glucose, inhibit the secretion of insulin, and thereby affect pancreas islet functions of patients [15]. Our results indicated that Shenqi Jiangtang granules combined with acupuncture was more effective than acupuncture alone in alleviating clinical symptoms and improving pancreas islet functions of T2DPN patients with dual defficiency of qi and yin. Yuan-primordial points were the main acupoints for acupuncture, including Zusanli, the sea of blood, Taixi, Taichong, Taibai, Chongyang, Qiuxu, Chingku, etc. Acupuncture at Zusanli acupoint can bi-directionally regulate gastrointestinal physiological activities, stimulate peroxidases such as GSH Px to promote hydrogen peroxide decomposition, protect epithelial cell membranes from damage, improve pancreas islet function, and relieve clinical symptoms of patients [16]. Acupuncture at Taichong acupoint can decrease the cytokine content in pancreatic islet β cells, increase insulin receptors, enhance pancreas islet function, improve insulin resistance, and thus alleviate symptoms such as excessive eating, frequent hunger and fatigue in patients [17]. Shenqi Jiangtang granules mainly consists of ginsenoside, Astragalus Radix, Poria cocos, Schisandra Chinensis Fructus, Dioscoreae Rhizoma, Rehmanniae Radix, Trichosanthis Radix, Ophiopogonis Radix, etc. Among them, ginsenoside can nourish spleen and lung, Astragalus Radix, can tonify spleen and benefit qi, Poria cocos can strengthen the spleen and stomach, Schisandra Chinensis Fructus can generate body fluids and stop sweating, Dioscoreae Rhizoma can nourish kidney and benefit essence, Rehmanniae Radix can nourish yin and strengthen kidney, Trichosanthis Radix can generate fluids and alleviate thirst, and Ophiopogonis Radix can nourish yin and generate fluids. These medicinal materials together can benefit qi, nourish yin, tonify spleen and generate fluids [18]. Modern pharmacology revealed that Astragalus polysaccharides are one of the main activities of Astragalus Radix, which can increase the activity of hypothalamic-pituitary-adrenal axis, alleviate glucose and lipid metabolism disorders, regulate mitochondrial function to control metabolic memory, and effectively control blood glucose level, thereby improving symptoms such as fatigue, lack of energy, and laziness in speech [19]. Poria cocos polysaccharides, as Poria cocos extract, can repair function of pancreatic islet β cells, enhance pancreas islet function, increase the body’s glucose uptake rate, and alleviate symptoms such as lack of energy, laziness in speech, and lukewarm hands and feet [20]. Moreover, Shenqi Jiangtang granules with multi-ingredients and multi-targets characteristics, it exhibited a beneficial effect on ameliorating insulin resistance [21]. Hence, treatment of Shenqi Jiangtang granules combined with acupuncture can alleviate excessive eating, frequent hunger, fatigue, lack of energy, laziness in speech and lukewarm hands and feet, and improve pancreas islet function in T2DPN patients with dual deficiency of qi and yin, which was more effective than acupuncture alone.
Chronic high blood glucose in T2DPN patients activates glucose bypass metabolism and metabolizes excess glucose through specific bypass pathways, during which a large amount of reduced coenzyme II is consumed, leading to insufficient synthesis of nitric oxide and the generation of substantial free radicals, and ultimately exacerbating nerve damage [22]. The results of this study proved that treatment of Shenqi Jiangtang granules combined with acupuncture had stronger effects than acupuncture treatment alone in relieving nerve damage in T2DPN patients with dual deficiency of qi and yin. Acupuncture at Taixi acupoint can promote the proliferation of β cells, enhance the ability of adipose tissue to absorb glucose, boost muscle anaerobic glycolysis, hinder the absorption of glucose in the intestine and lower blood glucose by affecting the binding of cholinergic transmitters from nerve ends and their receptors in the vagus, thereby alleviating nerve damage [23]. Stimulating Taixi and Zusanli acupoints can reduce the level of malondialdehyde, increase the activity of superoxide dismutase, effectively alleviate oxidative stress, and promote sensory nerve repair [24]. Shenqi Jiangtang granule has anti-inflammatory activity, it can decrease the serum concentration of inflammatory cytokines (tumor necrosis factor-α (TNF-α), IL-6, and IL-1β), along with suppressing the p-NF-κβ protein overexpression [21]. In line with modern pharmacology, ginsenosides in Shenqi Jiangtang granules are mainly responsible for repressing NF-κβ activation by blocking the binding of lipopolysaccharides (LPS) to immune cells such as Toll-like receptor 4 on macrophages, which thus generate a certain improving effect on neuroinflammatory damage in T2DPN patients [25]. Schisandra Chinensis Fructus water extract can block NF-κβ signaling pathwayto inhibit TNF-α and induce the expression of matrix metalloproteinase-9, migration and production of reactive oxygen in human aortic smooth muscle cells (HASMCs), ultimately alleviating neurological damage [26]. Collectively, treatment of Shenqi Jiangtang granules combined with acupuncture was more effective in alleviating nerve damage in T2DPN patients with dual deficiency of qi and yin, relative to acupuncture treatment alone.
In addition, the SNCV of a patient can be reduced by DPN, which can affect sensation and movement. Studies have shown that acupoint therapy can improve SNCV and reduce DPN symptoms [27-29]. In this study, the SNCV and MNCV of median nerve, posterior tibial nerve and common peroneal nerve of T2DPN patients with dual deficiency of qi and yin were elevated after treatment with Shenqi Jiangtang granules combined with acupuncture. It indicated that Shenqi Jiangtang granules combined with acupuncture has a good therapeutic efficacy for T2DPN patients. In addition, this study unveiled that no severe adverse reactions occurred during treatment in the two groups of patients, indicating the high safety of Shenqi Jiangtang granules combined with acupuncture in treating T2DPN patients with dual deficiency of qi and yin. However, there are some limitations to be addressed: (1) small samples; (2) a paucity of discussion on the long-term therapeutic effect of Shenqi Jiangtang granules combined with acupuncture. Hence, further in-depth research is required.
5 Conclusion
To conclude, Shenqi Jiangtang granules combined with acupuncture has specific therapeutic efficacy towards T2DPN with dual deficiency of qi and yin, which can relieve clinical symptoms, improve pancreas islet function and reduce nerve damage, with high safety.
Back Matter
Acknowledgments
Not applicable.
Conflicts of Interest
The authors declare no conflicts of interest.
Author Contributions
Conceptualization, Y.J.; Data curation, Z.M.; Formal analysis, X.J.; Methodology, Y.J.; Writing-original draft, Z.M.; Writing-review and editing, X.J. All authors have read and agreed to the published version of the manuscript.
Ethics Approval and Consent to Participate
This study was authorized by the Ethics Committee of our hospital and the written informed consent was obtained from all patients.
Funding
This research received no external funding.
Availability of Data and Materials
The data presented in this study are available on request from the corresponding author.
Supplementary Materials
Not applicable.
References
- Wu BR, Niu ZY, Hu F. Study on Risk Factors of Peripheral Neuropathy in Type 2 Diabetes Mellitus and Establishment of Prediction Model. Diabetes & Metabolism Journal 2021; 45(4): 526-538.
- Wong YH, Wong SH, Wong XT, et al. Genetic associated complications of type 2 diabetes mellitus). Panminerva Medica 2022; 64(2): 274-288.
- Prevost J, Lambert J. TENS and EMS Treatment for Diabetic Peripheral Neuropathy. Alternative Therapies In Health And Medicine 2022; 28(6): 57-59.
- Elafros MA, Andersen H, Bennett DL, et al. Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments. Lancet Neurology 2022; 21(10): 922-936.
- Yang D, Liang XC. Strategies and Research Progress of Chinese Medicine in Prevention and Treatment of Diabetic Peripheral Neuropathy. Chinese Journal of Integrative Medicine 2018; 24(10): 794-800.
- Piao YL, Liang XC. Chinese Medicine in Diabetic Peripheral Neuropathy: Experimental Research on Nerve Repair and Regeneration. Evidence-Based Complementary and Alternative Medicine 2012; 2012: 191632.
- Li BB, Feng CW, Qu YY, et al. Research progress on central mechanism of acupuncture treatment for chronic fatigue syndrome. World Journal of Acupuncture - Moxibustion 2023; 33(3): 198-203.
- Zhang Q, Xiao XH, Zheng J, et al. Shenqi Jiangtang Granule Ameliorates Kidney Function by Inhibiting Apoptosis in a Diabetic Rat Model. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 3240618.
- Li T, Li H, Wu Y, et al. Efficacy and safety of Shenqi Jiangtang Granules plus oral hypoglycemic agent in patients with type 2 diabetes mellitus: A protocol for systematic review and meta-analysis of 15 RCTs. Medicine 2021; 100(5): e23578.
- Tang J, Fan L, Lv C, et al. Efficacy of Shenqi Jiangtang Granules-Assisted Western Medicine in the Treatment of Gestational Diabetes Mellitus (GDM). Iranian Journal of Public Health 2021; 50(11): 2191-2201.
- Zhang LJ, Hu XQ, Yu JJ, et al. Meta-analysis of Shenqi Jiangtang Granules combined with western medicine on adverse pregnancy outcomes in women with gestational diabetes mellitus. Zhongguo Zhong Yao Za Zhi 2022; 47(10): 2811-2818.
- Bril V, Zochodne D, Feldman E, et al. Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011; 76(20): 1758-1765.
- Yang ZQ, Tang YQ, Du YP, et al. Development of clinical trial of new drugs of traditional Chinese medicines. Zhongguo Zhong Yao Za Zhi 2021; 46(7): 1691-1695.
- Hewage S, Somandaram N, Ratnasamy V, et al. Active sreening of patients with diabetes mellitus for pulmonary tuberculosis in a tertiary care hospital in Sri Lanka. PLoS One 2021; 16(4): e0249787.
- Menon AS, Dixit A, Garg MK, et al. Cardiac autonomic neuropathy in patients with Type 2 diabetes mellitus at high risk for foot ulcers. Indian Journal of Endocrinology and Metabolism 2017; 21(2): 282.
- Peng MF, Li K, Wang C, et al. Therapeutic effect and mechanism of electroacupuncture at Zusanli on plasticity of interstitial cells of Cajal: a study of rat ileum. BMC Complementary and Alternative Medicine 2014; 14: 186.
- Liu Y, Xu TC, Yu Z, et al. Investigation on the mechanism of acupuncture in treatment of diabetes mellitus type 2 based on the network of islet macrophages-pancreatic adipose cells-islet β cells. Zhongguo Zhen Jiu 2022; 42(4): 433-436.
- Li RL, Dong TW, Wei JG, et al. Meta-Analysis of the Therapeutic Effect of Shenqi Jiangtang Granule on Type 2 Diabetes Mellitus. Evidence-Based Complementary and Alternative Medicine 2020; 2020: 5754823.
- Si MW, Yang MK, Fu XD. Effect of hypothalamic-pituitaryadrenal axis alterations on glucose and lipid metabolism in diabetic rats. Genetics and Molecular Research 2015; 14(3): 9562-9570.
- Sun SS, Wang K, Ma K, et al. An insoluble polysaccharide from the sclerotium of Poria cocos improves hyperglycemia, hyperlipidemia and hepatic steatosis in ob/ob mice via modulation of gut microbiota. Chinese Journal of Natural Medicines 2019; 17(1): 3-14.
- Shi S, Sun M, Liu Y, et al. Insight into Shenqi Jiangtang Granule on the improved insulin sensitivity by integrating in silico and in vivo approaches. Journal of Ethnopharmacology 2022; 282: 114672.
- Haythorne E, Lloyd M, Walsby-Tickle J, et al. Altered glycolysis triggers impaired mitochondrial metabolism and mTORC1 activation in diabetic β-cells. Nature Communications 2022; 13(1): 6754.
- Zhang SQ, Wang YJ, Zhang JP, et al. Brain activation and inhibition after acupuncture at Taichong and Taixi: resting-state functional magnetic resonance imaging. Neural Regeneration Research 2015; 10(2): 292-297.
- Chung JY, Yoo AY, Im W, et al. Electroacupuncture at the Zusanli And Baihui Acupoints Ameliorates Type-2 Diabetes-Induced Reductions in Proliferating Cells and Differentiated Neuroblasts in the Hippocampal Dentate Gyrus With Increasing Brain-Derived Neurotrophic Factor Levels. Journal of Veterinary Medical Science 2015; 77(2): 167-173.
- Li LC, Piao HM, Zheng MY, et al. Ginsenoside Rh2 attenuates allergic airway inflammation by modulating nuclear factor-κB activation in a murine model of asthma. Molecular Medicine Reports 2015; 12(5): 6946-6954.
- Kang YS, Han MH, Hong SH, et al. Anti-inflammatory Effects of Schisandra chinensis (Turcz.) Baill Fruit Through the Inactivation of Nuclear Factor-κB and Mitogen-activated Protein Kinases Signaling Pathways in Lipopolysaccharide-stimulated Murine Macrophages. Journal of Cancer Prevention 2014; 19(4): 279-287.
- Feng Y, Fang Y, Wang Y, et al. Acupoint Therapy on Diabetes Mellitus and Its Common Chronic Complications: A Review of Its Mechanisms. BioMed Research International 2018; 2018: 3128378.
- Tay JS, Kim YJ. Efficacy of moxibustion in diabetes peripheral neuropathy. Medicine 2021; 100(49): e28173.
- Zhang S, Xie X, Zhang J. Therapeutic effect observation on diabetic foot peripheral neuropathy by time-related along-meridian acupressure combining with Traditional Chinese medicine foot bath. Chinese Nursing Research 2019; 4: 696-698.